Despite herd immunity following Omicron, vaccine makers are still working to produce an Omicron jab to be rolled out in March 2022. Why?
- Omicron infection is rapidly ripping through populations, leaving natural herd immunity in its wake. Despite that, vaccine makers are still hard at work to produce an Omicron-specific injection, slated to be rolled out in March 2022, well after a majority have already been infected
- After the rollout of a fourth dose, Israel now has the highest COVID case rate per capita of any country in the world since the beginning of the pandemic
- The definition of what it means to be “fully vaccinated” against COVID keeps shifting with the rollout of additional boosters. Vaccine passport holders in various countries face the prospect of losing their “privileges” unless they get boosted
- Government data from Australia, the U.S., Canada, Scotland and England suggest people who have received at least two shots are now showing signs of serious immune system degradation
- This immune erosion, aka, acquired immune deficiency, is thought to account for elevated rates of myocarditis and other post-jab conditions, some of which can result in death if progressing rapidly, or chronic diseases if moving more slowly
A major driver for this U-turn in the pandemic narrative is the emergence of the Omicron variant which, by mid-January 2022, accounted for 99.5% of all COVID cases in the U.S.1
The infection, which is far milder than previous ones, is ripping through populations, leaving natural herd immunity in its wake. Despite that, vaccine makers are still hard at work to produce an Omicron-specific injection.2 Pfizer has promised to have one ready by March 2022.3
The question is why, seeing how by the time the shot is released, just about everybody will have been exposed. If natural herd immunity is already maxed out, what good could a “vaccine” possibly do?